FAS and autoimmune lymphoproliferative syndrome: For patients meeting ALPS criteria, with “consistent” or “suspicious” ALPS Immune-panel results, an abnormal Fas-mediated apoptosis, and a negative family history, further testing for somatic variants using sorted DNTC or NGS panel with higher sensitivity (< 5%) for somatic variants should be considered.